Gender-specific pharmacology: implications for therapy.
Historically, research into drugs and diseases has assumed that beyond the reproductive system, gender differences did not exist or were not relevant. Interest in recognizing the importance of gender-based differences in pharmacology and disease has been fueled in recent years by an increasing amount of data revealing variations in drug efficacy and side effect profiles between the genders as well as differences in disease prevalence.
Martin
Caren McHenry
CM
D001172:Arthritis, Rheumatoid / Q000453:epidemiology / Q000503:physiopathology; D001249:Asthma / Q000453:epidemiology / Q000503:physiopathology; D002561:Cerebrovascular Disorders / Q000453:epidemiology / Q000503:physiopathology; D002908:Chronic Disease; D003863:Depression / Q000453:epidemiology / Q000503:physiopathology; D004347:Drug Interactions; D004358:Drug Therapy; D005260:Female; D006331:Heart Diseases / Q000453:epidemiology / Q000503:physiopathology; D006333:Heart Failure / Q000453:epidemiology / Q000503:physiopathology; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000453:epidemiology / Q000503:physiopathology; D008297:Male; D010599:Pharmacokinetics; D010600:Pharmacology; D015995:Prevalence; D012737:Sex Factors